Jan 28 (Reuters) - U.S. drugmaker Eli Lilly (LLY.N), opens new tab signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the Germany-based startup said on Wednesday, to develop and ...
Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 ...
Forbes contributors publish independent expert analyses and insights. Anisha Sircar is a journalist covering tech, finance and society. This voice experience is generated by AI. Learn more. This voice ...
Eli Lilly (LLY +0.33%) is close to doing something no other pharmaceutical company has ever done: reaching $1 trillion in market value. The company briefly touched that level in November but has since ...
Boston biotech Nimbus Therapeutics is teaming up with Eli Lilly & Co. to develop a new oral obesity treatment in a deal worth up to $1.3 billion, the company announced Tuesday. It’s the latest move in ...
In the sunny landscapes of Southern California, where the flowers bloom and the sun shines bright, there is a buzzing hero known as Eli the Bee Guy. When it comes to beehive removal near me, Eli has ...
The Washington Nationals shocked everyone when they picked Eli Willits No. 1 in the 2025 draft. Long connected to Ethan Holliday and then later breakout collegiate pitcher Kade Anderson, the fact they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results